4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Barzolvolimab in Patients With Prurigo Nodularisprurigo nodularisActive, not recruitingPhase 22026-08-04NCT06366750
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoAcneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorderRecruitingPhase 42026-07-29NCT07524946
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseAcneiform Eruptions, Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, acne, bacterial infectious disease, dermatitis, hidradenitis, hidradenitis suppurativa, sebaceous gland disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorderActive, not recruitingPhase 22026-06-30NCT06993610
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaChronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticariaActive, not recruitingPhase 32026-03-25NCT06445023